Allarity Therapeutics, Inc. (ALLR) vs Jin Medical International Ltd. (ZJYL)

A side-by-side comparison of Allarity Therapeutics, Inc. and Jin Medical International Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALLR vs ZJYL

growth of $100 · dividends reinvested · last 4y
ALLR -100.0% (-93.7%/yr)ZJYL -75.1% (-29.4%/yr)ZJYL compounded faster over this window
Log scale — wide-divergence pair
0001101001k10kStart $100202420252026$0$25
ALLR ZJYL

ALLR vs ZJYL: by the numbers

  • •ALLR is the larger company ($16M vs $16M market cap).
  • •ZJYL is profitable (5.76% net margin) while ALLR runs a net loss (-3575.07%).

Metrics side by side

Valuation

MetricALLRZJYL
P/S ratio45.44N/A
P/B ratio4.430.51

Profitability

MetricALLRZJYL
Gross margin107.54%29.22%
Operating margin-3939.06%2.94%
Net margin-3575.07%5.76%
ROE-348.81%4.02%
ROIC-41.81%1.09%

Growth (annualized)

MetricALLRZJYL
Revenue CAGR (5Y)N/A5.02%
EPS CAGR (5Y)N/A6.40%

Frequently asked

Is ALLR or ZJYL more profitable?
ZJYL runs the higher net margin — ALLR at -3575.07% versus ZJYL at 5.76%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.